60 DEGREES PHARMA INC (SXTP) Stock Income Statement
USA - NASDAQ:SXTP - US83006G4010 - Common Stock
1.23 USD
-0.07 (-5.38%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 973.70K | 681.40K | 253.60K | 511.20K | 6.35M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | 6.60K | 8.60K | 48.10K | -3.90K | 8.60K | |||
| Cost Of Goods | 353.20K | 384.80K | 474.60K | 432.40K | 850.70K | |||
| Gross Profit | 620.60K | 296.60K | -221.00K | 78.80K | 5.50M | |||
| Operating Expenses | 8.33M | 10.01M | 4.93M | 1.83M | 6.63M | |||
| Research and Development | 2.21M | 4.99M | 691.80K | 525.60K | 5.51M | |||
| Selling, General, and Administrative Expenses | 6.12M | 5.03M | 4.24M | 1.30M | 1.12M | |||
| Operating Income | -7.71M | -9.71M | -5.15M | -1.75M | -1.12M | |||
| Interest Income/Expense | -215.10K | 1.66M | -2.72M | -4.50M | -3.17M | |||
| Other Income/Expense | 104.90K | 101.50K | 5.30M | -43.20K | 37.50K | |||
| Non Recurring Items | null | null | -1.23M | 120.70K | 0 | |||
| Income Before Taxes | -7.82M | -7.96M | -3.81M | -6.18M | -4.26M | |||
| Income Tax | 1.40K | 300 | 300 | 500 | 1.00K | |||
| Net Income | -8.31M | -8.43M | -3.99M | -6.18M | -4.25M | |||
| EBITDA | -7.64M | -9.66M | -5.10M | -1.72M | -1.09M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -9.7526 | -18.5454 | -60.396 | -66.5951 | -45.8037 | |||
| Non GAAP EPS | -21.659999999999997 | -38.2 | null | null | null | |||
| Statistics | ||||||||
| Gross Profit Margin | 63.74% | 43.53% | -87.15% | 15.41% | 86.61% | |||
| Profit Margin | -853.19% | -1237.22% | -1571.92% | -1209.25% | -66.93% | |||
| Operating Profit Margin | -791.85% | -1425.73% | -2032.57% | -342.41% | -17.69% | |||
All data in USD